Results reported here for all core components of the mammalian Ras pathway, and based on human-mouse comparisons (which probably diverged ~75 million years ago; e.g., ref. [ 68]), do not point in the same direction: upstream genes do not exhibit lower rates of evolution than those acting at the downstream part of the pathway.
Surprisingly, renin secretion was enhanced in vivo in Arap1−/− mice, which is probably explained by systemic rather than direct effects of angiotensin II on renin-producing cells.
Reduced stress-induced GC release was connected to increased monoaminergic activity in the vendor-derived mice which is probably mediated by adaptive inhibitory central noradrenergic pathways.
Our data showed a possible difference in the learning basal line between transgenic and wild mice, which is probably related to the genetic characteristics of the groups.
In line, we observed high levels of IL-13 and IL-5 release in these mice, which are probably driven by high IL-2 levels and STAT5 activation (47, 48).
When the data for all six treatment groups of mice were analysed with one-way ANOVA, no significant difference in GSH or MDA content or SOD activity between genotype groups was observed for either non-diabetic or diabetic mice, which is probably largely because of the limited number of mice.
The overall number of zone entries and time in zones for GluN2B KI mice showed a slight increase compared to WT mice, which is probably a reflection of the statistically non-significant increased activity of KI as seen in the covered distance and mean velocity.
The lack of association between reduced KCNQ2/3 channel activity and fusiform cell hyperactivity may be explained by the hyperpolarized RMP in fusiform cells from 4 days noise-exposed mice, which is probably due to plasticity in some other ionic conductance(s) ('Discussion').
Although not very pronounced, the number of T and B cells found in the ears of NCR1gfp/gfp mice was about 10% lower than in NCR1+/gfp mice (Supporting Information Fig. 1A) or WT mice (not shown), which probably reflects the diminished swelling observed in the NCR1gfp/gfp mice.
In contrast, we found a slight upregulation in the levels of some mouse and human proangiogenic factors, which probably represents a compensatory mechanism.
